Approach to Vitamin B12 Deficiency

Initial Assessment and Testing

• The British Medical Journal recommends measuring either active B12 or total B12 as first-line testing when vitamin B12 deficiency is suspected, with active B12 being more accurate but total B12 being more cost-effective 1
• Biochemical B12 deficiency is confirmed when serum cobalamin is low combined with elevated functional biomarkers: homocysteine or methylmalonic acid 2
• Clinical B12 deficiency requires biochemical deficiency plus macrocytosis and/or neurological symptoms 2

Risk Factors to Identify

• The British Medical Journal recommends screening for high-risk conditions, including dietary factors such as vegan/vegetarian diets, and gastrointestinal conditions such as atrophic gastritis and celiac disease 1
• The Clinical Nutrition journal notes that gastrointestinal conditions, including >20 cm distal ileum resection and bariatric surgery, are also risk factors for B12 deficiency 2

Treatment Protocol

• The Clinical Nutrition journal recommends administering hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement, then transitioning to maintenance with 1 mg intramuscularly every 2 months for life for patients with neurological involvement 2
• The Praxis Medical Insights guideline recommends giving hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance of 1 mg intramuscularly every 2-3 months lifelong for patients without neurological involvement 3

Monitoring Strategy

• The Clinical Nutrition journal recommends screening high-risk patients yearly for B12 deficiency 2
• The Praxis Medical Insights guideline recommends checking serum B12, homocysteine, and methylmalonic acid every 3 months until stabilization, and then monitoring once yearly 3

Special Populations

• The Praxis Medical Insights guideline recommends administering 1 mg intramuscularly every 3 months or 1000-2000 μg daily orally indefinitely for post-bariatric surgery patients 3
• The Praxis Medical Insights guideline recommends checking B12 levels every 3 months throughout pregnancy for pregnancy after bariatric surgery 3

Common Pitfalls

• The Praxis Medical Insights guideline notes that patients require lifelong therapy when malabsorption is the cause, and that treatment should not be discontinued even if levels normalize 3
• The Praxis Medical Insights guideline recommends monitoring for recurrent neurological symptoms and increasing injection frequency if symptoms return 3

B12 Injection Frequency for Low B12 Levels

Initial Treatment Protocol

• The American Journal of Hematology recommends giving hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks (or daily for days 1-10), followed by maintenance therapy, for patients without neurological involvement 4, 5, 6

Maintenance Therapy

• The American Journal of Hematology suggests that the standard maintenance regimen is not every two weeks, but rather 1 mg intramuscularly every 2-3 months for life, for patients without neurological involvement 4, 5, 6

Oral Alternative

• The American Journal of Hematology states that oral cyanocobalamin 1000-2000 mcg daily is therapeutically equivalent to parenteral therapy for most patients, including those with malabsorption 4, 5

Vitamin B12 Supplementation Guidelines

Special Population Considerations

• Patients with Crohn's disease and ileal resection >20 cm should receive 1000 mcg intramuscularly every month indefinitely for prophylaxis, and should be screened yearly for B12 deficiency, as shown in a retrospective study of 36 Crohn's disease patients who received oral therapy (1200 mg daily) and achieved effective treatment of vitamin B12 deficiency 7
• A retrospective study of 36 Crohn's disease patients showed that oral therapy (1200 mg daily) can be effective in treating vitamin B12 deficiency, with a similar outcome to intramuscular administration 7

Hydroxocobalamin Preferred for Inherited Cobalamin Metabolism Disorders

Genetic Metabolic Defects

• Patients with inherited defects in cobalamin transport or intracellular metabolism (e.g., mutations in TCN2, MMACHC, MMADHC, MTRR, or MTR) should receive hydroxocobalamin or methylcobalamin rather than cyanocobalamin, because cyanocobalamin requires enzymatic conversion that is impaired in these conditions. 8

Serum Vitamin B12 Reference Ranges and Clinical‑Trial Inclusion Criteria

Reference Range for Serum B12

• In adult populations, the normal serum vitamin B12 concentration is approximately 200–900 pg/mL (150–665 pmol/L) — values above this range are considered markedly elevated and likely reflect exogenous supplementation rather than physiological status. 9

B12 Levels Used for Stroke‑Prevention Trial Eligibility

• Stroke‑prevention studies typically exclude participants whose serum B12 exceeds the 95th percentile (greater than ~637 pmol/L or ≈864 pg/mL), because such high levels suggest external supplementation and may confound assessment of the intervention’s efficacy. 9